1. Home
  2. LCNB vs BCYC Comparison

LCNB vs BCYC Comparison

Compare LCNB & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

N/A

Current Price

$19.57

Market Cap

281.1M

Sector

Finance

ML Signal

N/A

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

N/A

Current Price

$3.69

Market Cap

256.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LCNB
BCYC
Founded
1877
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.1M
256.5M
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
LCNB
BCYC
Price
$19.57
$3.69
Analyst Decision
Hold
Buy
Analyst Count
3
9
Target Price
★ $20.83
$9.17
AVG Volume (30 Days)
19.2K
★ 402.9K
Earning Date
10-15-2026
10-29-2026
Dividend Yield
★ 4.48%
N/A
EPS Growth
★ 68.04
N/A
EPS
★ 1.35
N/A
Revenue
★ $6,445,000.00
N/A
Revenue This Year
$11.08
N/A
Revenue Next Year
$0.51
N/A
P/E Ratio
$14.71
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.83
$3.33
52 Week High
$21.32
$7.83

Technical Indicators

Market Signals
Indicator
LCNB
BCYC
Relative Strength Index (RSI) 52.03 49.35
Support Level $18.44 $3.44
Resistance Level $20.29 $4.08
Average True Range (ATR) 0.47 0.20
MACD -0.02 0.01
Stochastic Oscillator 35.37 36.11

Price Performance

Historical Comparison
LCNB
BCYC

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: